Executive Assistant at Axsome Therapeutics Inc

San Diego, California, United States

Apply Now

$89,000 – $112,000Compensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

BiotechnologyIndustries

Requirements

5+ years of administrative experience supporting executives, preferably in biotech or tech companies
Strong proficiency in office software (Microsoft Office, etc.) and communication platforms (Slack, Zoom, etc.)
Experience independently coordinating and booking domestic and international travel without the use of a travel agency
Exceptional organizational skills with the ability to manage multiple tasks and prioritize effectively
Excellent written and verbal communication skills with a keen attention to detail
Strong interpersonal skills and the ability to work effectively with a wide range of individuals, both internally and externally
Ability to work independently and exercise good judgment
Proactive and solutions-oriented mindset with the ability to anticipate needs and resolve issues effectively

Responsibilities

Support coordination of meetings/events, ensuring effective time management and prioritization of meetings, events, and appointments
Provide support for special projects, including monitoring and managing tasks and deadlines, ensuring timely completion and follow-up
Handle sensitive and confidential information with integrity and professionalism
Support calendar management and travel arrangements
Prepare and distribute correspondence, reports, and meeting materials
Support general office operations
Assist with data entry, filing, and record keeping

Skills

Microsoft Office

Slack

Zoom

Calendar Management

Travel Coordination

Expense Management

Meeting Coordination

Data Entry

Confidential Information Handling

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free